Home   >  
Angiogenesis/Protein Tyrosine Kinase
  >  
Integrin

Classified by application

All Products

Signaling Pathways

Research Areas

Nature products

Antibodies

Peptides

Catalysts

Impurities

Intermediate

Raw Materials

Integrin

Chemical Structure Cat. No. Product Name CAS No.
Carotegrast Chemical Structure
BCP40366 Carotegrast 401904-75-4
Carotegrast is an anti-inflammatory agent.
Carotegrast methyl Chemical Structure
BCP40218 Carotegrast methyl 401905-67-7
Carotegrast methyl is an orally-active small molecule that antagonises the α4 integrin receptor.
A 286982 Chemical Structure
BCP37784 A 286982 280749-17-9
A 286982 is a potent inhibitor of the LFA-1/ICAM-1 interaction (IC50 = 44 and 35 nM in LFA-1/ICAM-1 binding and LFA-1-mediated cell adhesion assays, respectively).
QLT0267 Chemical Structure
BCP25954 QLT0267 866409-68-9
QLT0267 is an ATP-competitive selective inhibitor of integrin-linked kinase (ILK).
Vedolizumab Chemical Structure
BCP26256 Vedolizumab 943609-66-3
Vedolizumab is a humanized monoclonal antibody that targets the α4β7 integrin for the treatment of ulcerative colitis and Crohn's disease.
ILK-IN-1 Chemical Structure
BCP23690 ILK-IN-1 1333146-24-9
OSU-T315 (1,5-regioisomer) is a potent and specific integrin-linked kinase (ILK) inhibitor.
ILK-IN-2 Chemical Structure
BCP30839 ILK-IN-2 2070015-22-2
ILK-IN-2 is a ILK inhibitor.
TR-14035 Chemical Structure
BCP30639 TR-14035 232271-19-1
TR-14035 is a a dual alpha4beta7(IC50=7 nM)/alpha4beta1 (IC50=87 nM) integrin antagonist .
Abciximab Chemical Structure
BCP30526 Abciximab 143653-53-6
Abciximab is a glycoprotein IIb/IIIa receptor antagonist and a platelet aggregation inhibitor mainly used during and after coronary artery procedures like angioplasty to prevent platelets from sticking together and causing thrombus (blood clot) formation within the coronary artery.
GSK3008348 Chemical Structure
BCP17153 GSK3008348 1629249-33-7
GSK3008348 is an Integrin alphaV inhibitor.
123下一页共 29 条记录 1 / 3 页 
0086-15971444841